Novartis Partners with Microsoft to Bring AI into Clinical Trials | Marion Chalumeau, Novartis

Big Pharma is welcoming Big Tech -- at least that's the case at Novartis, where the global giant has partnered with Microsoft to bring advanced AI technology into the company to help, at least initially, with clinical trials. Marion Chalumeau, Head of Digital & Innovation for Novartis Oncology in Spain, shares some insight on how pharma is attempting to disrupt its own business processes -- from R&D to clinical trials -- by integrating next gen tech that will help trim costs and reduce time to market. Novartis is focused on 'going big and going digital', hence the partnership with Microsoft, which is expected to drop costs associated with clinical trials by 25% while also improving the patient experience in the process. Where else with Novartis focus as it attempts to bring new solutions to its Oncology business? Tune in to find out!

Filmed at Barcelona Health Hub Summit in Barcelona, Spain, October 2019.

***
Jessica DaMassa, the emerging ‘It girl’ of health tech interviewing, chats it up with the ‘who’s who’ of the health innovation set on WTF Health.

Catch 100s of interviews with leading health tech startups and digital health innovators and the VC investors, accelerators, health insurance companies, pharmas, and hospital systems helping bring their new ideas into the healthcare ‘establishment.’

From AI, Big Data, and blockchain to AR/VR, digital therapeutics, payment model innovation, health policy, and investing, Jessica helps you spot the trends and figure out what’s next…or, ‘What’s The Future?’ Health. (Yes. That’s really what the acronym means. 😉 )

To learn more about WTF Health, find out where Jess will be next, or throw some dollars at our show, check out these links below.


Sponsored by Bayer G4A, Livongo, GuideWell & The Health Care Blog